Skip to main content
OpenTrials

Clinical trial condition

DNA Virus Infections

Explore clinical trials studying DNA Virus Infections. Study availability and eligibility vary by location and protocol.

3,911 public trials 503 recruiting studies
Refine in advanced search Browse all conditions

DNA Virus Infections trial results

Completed

B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B

NCT04193189

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +19 more
Locations
  • Alabama CRS Birmingham, Alabama, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • UCSD Antiviral Research Center San Diego, California, United States
  • Ucsf Hiv/Aids Crs San Francisco, California, United States
View all 41 locations
View Trial Details
Completed

A Study to Test GlaxoSmithKline's (GSK) Herpes Zoster (HZ) Subunit Vaccine's Long-term Immune Response in Previously Vaccinated Kidney Transplant Adults and Then to Test if 2 Additional Doses of the Vaccine Are Safe and Able to Generate an Immune Response

NCT04176939

Conditions
DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations
  • GSK Investigational Site Brussels, Belgium
  • GSK Investigational Site Toronto, Ontario, Canada
  • GSK Investigational Site Toronto, Ontario, Canada
  • GSK Investigational Site Helsinki, Finland
View all 15 locations
View Trial Details
Completed

A Study to Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From ≥18 Years of Age to <50 Years of Age

NCT05995275

Conditions
Animal Diseases, DNA Virus Infections, Infections, +7 more
Locations
  • Bradford Teaching Hospitals NHS Foundation Trust Bradford, United Kingdom
  • University Hospitals Bristol and Weston NHS Foundation Trust Bristol, United Kingdom
  • Lakeside Healthcare Research Corby, United Kingdom
  • University Hospitals of Leicester Leicester, United Kingdom
View Trial Details
Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors

NCT04242199

Conditions
Adenocarcinoma, Adenoma, Advanced Solid Tumor, +67 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Henry Ford Hospital Detroit, Michigan, United States
  • Upmc Cancercenter Pittsburgh, Pennsylvania, United States
  • Md Anderson Cancer Center Houston, Texas, United States
View all 21 locations
View Trial Details

Related conditions